Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective
Overview
Authors
Affiliations
Before the second half of the 20th century, most clinical decision making was based on expert opinion. By the 1960s, experience in actuarial and research cohort studies had provided strong evidence that blood pressure was an important risk factor for cardiovascular disease. The landmark 1967 and 1970 Veterans Administration Cooperative Study trials confirmed the value of antihypertensive drug therapy in preventing stroke, myocardial infarction, and heart failure in adults with high levels of diastolic blood pressure. They also provided an impetus to develop the first blood-pressure-related clinical practice guideline in 1977. In subsequent years, more structured and comprehensive blood-pressure guidelines have evolved to become a major resource in clinical and public health practice. Despite some limitations, these guidelines provide useful evidence-based guidance for diagnosis and management of high blood pressure. The core advice in most of the current comprehensive blood pressure guidelines is more similar than different. Modelling studies suggest that better adherence to guideline recommendations would result in a lower average blood pressure and substantial improvement in public health.
Use and Cost Patterns of Antihypertensive Medications in the United States From 1996 to 2021.
Jacobs J, Rodgers A, Bellows B, Hernandez I, Wang N, Derington C Hypertension. 2024; 81(11):2307-2317.
PMID: 39229724 PMC: 11483193. DOI: 10.1161/HYPERTENSIONAHA.124.23509.
Editors' Commentary on the 2023 ESH Management of Arterial Hypertension Guidelines.
Whelton P, Flack J, Jennings G, Schutte A, Wang J, Touyz R Hypertension. 2023; 80(9):1795-1799.
PMID: 37354199 PMC: 10527435. DOI: 10.1161/HYPERTENSIONAHA.123.21592.
Ebinger J, Kauko A, Bello N, Cheng S, Niiranen T Eur J Prev Cardiol. 2023; 30(10):960-968.
PMID: 36866422 PMC: 10390234. DOI: 10.1093/eurjpc/zwad066.
Whelton P, Bundy J, Carey R Am J Hypertens. 2022; 35(11):905-914.
PMID: 35390116 PMC: 9629457. DOI: 10.1093/ajh/hpac045.
Global proliferation and clinical consequences of non-validated automated BP devices.
Whelton P, Picone D, Padwal R, Campbell N, Drawz P, Rakotz M J Hum Hypertens. 2022; 37(2):115-119.
PMID: 35279699 PMC: 11217746. DOI: 10.1038/s41371-022-00667-z.